Matthew Gura

Matthew Gura is an Associate at Baird Capital based in Chicago, Illinois, where his scope involves sourcing, evaluating, and managing growth equity investments across the technology and healthcare sectors. Promoted to his current role in 2023, he specializes in scaling technology-enabled services, healthcare, and industrial tech companies, supporting portfolio assets such as Real Chemistry. Prior to joining Baird Capital, Gura held investment roles at Pritzker Private Capital and worked as an analyst at the investment bank William Blair & Company. He holds a Bachelor of Business Administration degree in business administration and economics from the University of Michigan. Active in recent 2024 and 2025 healthcare tech growth equity deal expansions and industry panels, his current focus remains on executing growth-stage investments and building strategic partnerships with founders and management teams to scale tech-enabled businesses.